Atlas Trials

Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

Clinical trial NCT02732314 · COMPLETED

Trial details

NCT number
NCT02732314
Sponsor
Procter & Gamble Beauty
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Dermatitis, AtopicEczema
Start date
2016-03-01
Primary completion
2016-06-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.